A prospective single-arm phase II study of stereotactic magnetic-resonance-guided adaptive radiotherapy for prostate cancer: Early toxicity results.

Anna M E Bruynzeel,Shyama U Tetar,Swie S Oei,Suresh Senan,Cornelis J A Haasbeek,Femke O B Spoelstra, Anna H M Piet,Philip Meijnen, Marjolein A B Bakker van der Jagt,Tamara Fraikin,Berend J Slotman,Reindert J A van Moorselaar,Frank J Lagerwaard

International Journal of Radiation Oncology*Biology*Physics（2019）

引用 113|浏览42

暂无评分

摘要

This prospective study of MRgRT in patients with localized prostate cancer observed a low incidence of early GI and GU toxicity, both in clinician- and patient reported outcome measurements.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要